Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Dvl-3 Inhibitors

Dishevelled (Dvl) proteins are integral components of the Wnt signaling pathway, a complex cascade that regulates a multitude of cellular processes, including proliferation, differentiation, and migration. Among the various isoforms of Dishevelled, Dvl-3 is unique in its distribution and function. This protein acts as a crucial mediator, bridging the gap between Wnt receptor activation and downstream signaling events. The interaction of Wnt ligands with their respective Frizzled receptors results in the recruitment of Dvl proteins, subsequently initiating a signaling cascade that leads to the modulation of gene expression and other cellular outcomes. Dvl-3 inhibitors are specialized compounds designed to target and inhibit the function of the Dvl-3 protein. These inhibitors typically function by binding to specific regions of the Dvl-3 protein, preventing its interaction with other components of the Wnt signaling pathway. By disrupting these interactions, Dvl-3 inhibitors can modulate the Wnt pathway's output, offering insights into the intricate workings of this signaling cascade. The study and understanding of Dvl-3 inhibitors are of paramount importance in cellular biology, particularly in the context of Wnt signaling regulation. Through the use of these inhibitors, researchers can gain a deeper comprehension of the role of Dvl-3 in the broader spectrum of Wnt-mediated cellular processes. The development and application of Dvl-3 inhibitors in experimental settings can further elucidate the nuances of Wnt signaling and its impact on various cellular events.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

NSC 668036

144678-63-7sc-507412
5 mg
$175.00
(0)

NSC668036 disrupts Dvl-3 interaction with Frizzled, potentially down-regulating Dvl-3-mediated signaling pathways.

2-(1-Hydroxypentyl)-6-methyl-3-(2-phenylethyl)-1H-indole-5-carboxylic Acid

873841-43-1sc-490455
5 mg
$525.00
(0)

FJ9 inhibits Dvl-3's PDZ domain, possibly preventing its proper functioning and thus down-regulating its activity.

PKF118-310

84-82-2sc-364590
sc-364590A
5 mg
25 mg
$180.00
$651.00
(1)

PKF118-310 is a Wnt/β-catenin pathway inhibitor, potentially impacting Dvl-3 signaling.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$36.00
$117.00
$525.00
26
(1)

XAV939 stabilizes Axin, a negative regulator of Dvl-3, which might reduce Dvl-3 activity.

KY02111

1118807-13-8sc-397043
sc-397043A
5 mg
25 mg
$79.00
$336.00
(0)

KY02111 promotes degradation of Dvl-3 by stabilizing Axin, potentially reducing Dvl-3 levels.

IWR-1-endo

1127442-82-3sc-295215
sc-295215A
5 mg
10 mg
$82.00
$135.00
19
(1)

IWR-1 stabilizes Axin, a negative regulator of Dvl-3, possibly leading to Dvl-3 down-regulation.

JW 55

664993-53-7sc-364517
sc-364517A
10 mg
50 mg
$172.00
$726.00
(0)

JW55 inhibits the Wnt/β-catenin pathway, which might indirectly reduce Dvl-3 activity.

CCT036477

305372-78-5sc-391631A
sc-391631
5 mg
25 mg
$109.00
$437.00
1
(0)

CCT036477 is a Wnt signaling inhibitor, potentially impacting Dvl-3 signaling.

β-Catenin/Tcf Inhibitor, FH535

108409-83-2sc-221398
sc-221398A
10 mg
50 mg
$182.00
$374.00
7
(1)

FH535 inhibits the Wnt/β-catenin pathway, potentially leading to reduced Dvl-3 activity.

LGK 974

1243244-14-5sc-489380
sc-489380A
5 mg
50 mg
$359.00
$1295.00
2
(0)

LGK974 is a porcupine inhibitor, which might indirectly down-regulate Dvl-3 by impacting Wnt secretion.